Speed to clinic and to market is increasingly gaining importance among biopharmaceutical drug developers. Companies ranging from small Biotech to large Pharma are constantly driving to shorten development time and gain faster approval for their therapies that may address unmet medical needs.

You may also be interested in:
Mammalian
Cell Line Development
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center
Poster
3D Linkage Analysis with Digital PCR for rAAV Characterization Beyond Genomic Titer: Integrity and...
Abstract: Recombinant adeno-associated virus (rAAV) has emerged as the vector of choice for in vivo...
Dev on Demand - CGT - process development
Poster
Extracellular Vesicles: Engineering New Therapeutic Delivery Modalities
Abstract: Extracellular Vesicles (EVs), including exosomes, are emerging as promising natural...
Poster
Plasmid Engineering to Improve AAV Productivity and Packaging Efficiency
Abstract: The genome packaging efficiency (full to total capsid ratio, or F/T ratio) for...
Poster
Enabling Commercial AAV Manufacturing by Xcite® AAV Stable Producer Cell Lines
Abstract: The superior safety profile and transduction efficiency make AAV an excellent viral...
Poster
Overcoming Challenges to the Commercialization of Lentiviral-Based Therapies: A Scalable and Robust...
Abstract: Due to their ability to deliver larger cargo, transduce both dividing and non-dividing...
Article
Amazon updates dietary supplement quality policy
As you may be aware, Amazon has recently updated its policy with regards to quality requirements of...
Monoclonal Antibody Molecule
Article
Lonza Shows Flexibility with Ibex® Design Platform to Accommodate tRNA Synthetase-Derived mAbs
aTyr Pharma is a clinical stage biotech focused on translating findings from a proprietary tRNA...
Andrea Cubitt, Ph.D., Vice President External Scientific Alliances and Intellectual Property, aTyr Pharma
Article
A Small Biotech Recognizes the Importance in How You Think of Manufacturing in Selecting a CDMO
Manufacturing is crucial to the success of any drug development project but is too often overlooked....
micro image
Technical/Service brief
GS Discovery® Transient Expression System
With GS Discovery® you can.... Speed up therapeutic candidate selection with...
Microdosing graphic
Webinar (on-demand)
Micro-dosing – Powder in Capsule Technology Pathway from Development to Commercialization
Micro-dosing can accelerate the journey of a drug product from early development through to...
Webinar (on-demand)
Solving Bispecific Antibody Heavy-Light Chain Mispairing with bYlok® Technology
Lonza’s bYlok® bispecific pairing technology is an innovative solution that drives correct...
AAV manufacturing
Webinar (on-demand)
Improving AAV Productivity and Packaging Efficiency for Transient and Producer Cell Lines Through...
Adeno-associated virus (AAV) gene therapy has shown immense promise in treating various genetic...